(R)-2-(4'-(4-(((1-(2-chlorophenyl)ethoxy)carbonyl)aMino)-3-M..
| | (R)-2-(4'-(4-(((1-(2-chlorophenyl)ethoxy)carbonyl)aMino)-3-Methylisoxazol-5-yl)-[1,1'-biphenyl]-4-yl)acetic acid|4'-[4-[[[(1R)-1-(2-氯苯基)乙氧基]羰基]氨基]-3-甲基-5-異惡唑基]-聯(lián)苯-4-乙酸 基本信息 更多信息 |
| 中文名稱: | 4'-[4-[[[(1R)-1-(2-氯苯基)乙氧基]羰基]氨基]-3-甲基-5-異惡唑基]-聯(lián)苯-4-乙酸 | | 中文同義詞: | (R)-2-(4'-(4-(((1-(2-氯苯基)乙氧基)羰基)氨基)-3-甲基異惡唑-5-基)-[1,1'-聯(lián)苯]]-4-基)乙酸;化合物AM966;4'-[4-[[[(1R)-1-(2-氯苯基)乙氧基]羰基]氨基]-3-甲基-5-異惡唑基]-聯(lián)苯-4-乙酸;(R)-2-(4'-(4-(((1-(2-氯苯基)乙氧基)羰基)氨基)-3-甲基異惡唑-5-基)-[1,1'-聯(lián)苯]-4-基)乙酸;化合物AM966,10 MM DMSO 溶液;化合物:AM966 CAS:1228690-19-4;化合物:AM966 CAS:1228690-19-4;4'-[4-[[[(1R)-1-(2-氯苯基)乙氧基]羰基]氨基]-3-甲基-5-異惡唑基]-聯(lián)苯-4-乙酸 | | 英文名稱: | (R)-2-(4'-(4-(((1-(2-chlorophenyl)ethoxy)carbonyl)aMino)-3-Methylisoxazol-5-yl)-[1,1'-biphenyl]-4-yl)acetic acid | | 英文同義詞: | [1,1'-BIPHENYL]-4-ACETIC ACID, 4'-[4-[[[(1R)-1-(2-CHLOROPHENYL)ETHOXY]CARBONYL]AMINO]-3-METHYL-5-ISOXAZOLYL]-;(R)-2-(4'-(4-(((1-(2-chlorophenyl)ethoxy)carbonyl)aMino)-3-Methylisoxazol-5-yl)-[1,1'-biphenyl]-4-yl)acetic acid;AM 966;4'-[4-[[[(1R)-1-(2-Chlorophenyl)ethoxy]carbonyl]amino]-3-methyl-5-isoxazolyl]-[1,1'-biphenyl]-4-acetic acid;{4'-[4-({[(1R)-1-(2-Chlorophenyl)ethoxy]carbonyl}amino)-3-methyl-1,2-oxazol-5-yl]-4-biphenylyl}acetic acid;AM 966; AM-966;CS-2784;AM966,Lysophospholipid Receptor,inhibit,Inhibitor,AM-966,AM 966,LPL Receptor | | CAS號: | 1228690-19-4 | | 分子式: | C27H23ClN2O5 | | 分子量: | 490.93 | | EINECS號: | | ![(R)-2-(4'-(4-(((1-(2-chlorophenyl)ethoxy)carbonyl)aMino)-3-Methylisoxazol-5-yl)-[1,1'-biphenyl]-4-yl)acetic acid|4'-[4-[[[(1R)-1-(2-氯苯基)乙氧基]羰基]氨基]-3-甲基-5-異惡唑基]-聯(lián)苯-4-乙酸](/CAS/GIF/1228690-19-4.gif) |
|
| 按國家瀏覽(R)-2-(4'-(4-(((1-(2-chlorophenyl)ethoxy)carbonyl)aMino)-3-Methylisoxazol-5-yl)-[1,1'-biphenyl]-4-yl)acetic acid國外供應(yīng)商 |
中國供應(yīng)商 |
|
(R)-2-(4'-(4-(((1-(2-chlorophenyl)ethoxy)carbonyl)aMino)-3-Methylisoxazol-5-yl)-[1,1'-biphenyl]-4-yl)acetic acid 推薦供應(yīng)商 |
|
|
建議您優(yōu)先選擇企業(yè)會員,我們對企業(yè)會員產(chǎn)品有嚴格審核。 |
|
|